Cargando…
Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb–drug interactions in antiviral therapy
Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a v...
Autores principales: | Zhang, Feng, Liu, Wei, Huang, Jian, Chen, Qi-long, Wang, Dan-dan, Zou, Li-wei, Zhao, Yong-fang, Zhang, Wei-dong, Xu, Jian-guang, Chen, Hong-zhuan, Ge, Guang-bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237038/ https://www.ncbi.nlm.nih.gov/pubmed/34183756 http://dx.doi.org/10.1038/s41401-021-00697-2 |
Ejemplares similares
-
Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology Strategy
por: Zhu, De-wei, et al.
Publicado: (2022) -
Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy
por: Zhang, Feng, et al.
Publicado: (2021) -
Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019
por: Chen, Bowu, et al.
Publicado: (2023) -
Editorial: Pharmacokinetics of herbal medicines and herb-drug interactions
por: Jia, Wei-Wei, et al.
Publicado: (2022) -
Systematic elucidation of the mechanism of Jingyin granule in the treatment of Novel Coronavirus (COVID-19) Pneumonia via Network Pharmacology
por: Wang, Bingrui, et al.
Publicado: (2021)